The role of estrogen in the prevention of osteoporosis

Endocrinology and Metabolism Clinics of North America

Volumn 27, Issue 2, 1998, Pages 399-409

  Lindsay, R ^a  

^a HELEN HAYES HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BIOCHEMICAL MARKER; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CONJUGATED ESTROGEN; DEOXYPYRIDINOLINE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; ETIDRONIC ACID; FLUORIDE; HYDROXYPROLINE; NORETHISTERONE ACETATE; RALOXIFENE; TAMOXIFEN;

BONE MASS; BONE REMODELING; CLINICAL TRIAL; DOSE RESPONSE; FEMALE; FRACTURE; HUMAN; INTRAVAGINAL DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; OSTEOPOROSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SUBCUTANEOUS DRUG ADMINISTRATION; TRANSDERMAL DRUG ADMINISTRATION;

EID: 0031830769     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8529(05)70012-8     Document Type: Article

References (54)

1. S.K. Agarwal H.L. Judd Management of menopause Riggs B.L. Melton L.J. III Osteoporosis: Etiology, Diagnosis and Management 1996 Raven Press Philadelphia 351 370
2. F. Al-Azzawi D.M. Hart R. Lindsay Long-term effect of oestrogen replacement therapy on bone mass as measured by dual photon absorptiometry BMJ 294 1987 1261 1262
3. F. Albright C.H. Burnett O. Cope Acute atrophy of bone (osteoporosis) simulating hyperparathyroidism J Clin Endocrinol Metab 1 1941 711 716
4. S.J. Birge The role of estrogen deficiency in the aging central nervous system Lobo R.A. Treatment of the Postmenopausal Woman. Basic and Clinical Aspects 1998 Raven Press New York 153 157
5. J.P. Bonjour R. Rizzoli Bone acquisition in adolescence Marcus R. Feldman D. Kelsey J. Osteoporosis 1996 Academic Press San Diego 465 476
6. P. Bruns Die allgemeine hehre von den Knockenbruchen Deutsche Chwurgie 27 1882 1 400
7. A.M. Brzozowski A.C.W. Pike Z. Dauter Molecular basis of agonism and antagonism in the oestrogen receptor Nature 389 1997 753 757
8. D.B. Burr Remodeling and the repair of fatigue damage: Review Calcif Tissue Int 53 suppl 1 1993 S75 S80
9. J.A. Cauley D.G. Seeley K. Ensrud Estrogen replacement therapy and fractures in older women Ann Intern Med 122 1994 9 16
10. C. Christiansen R. Lindsay Estrogens, bone loss and preservation Osteoporos Int 1 1991 7 13
11. C. Christiansen B.J. Riis 17 Beta-estradiol and continuous norethisterone: A unique treatment for established osteoporosis in elderly women J Clin Endocrinol Metab 71 1990 836 841
12. S.R. Cummings D. Black K. Ensrud Urine markers of bone resorption predict hip bone loss and fractures in older women: The study of osteoporotic fractures [abstract] J Bone Miner Res 11 suppl 1 1996 S128
13. P.D. Delmas N.H. Bjarnson B.H. Mutlak Effects of raloxifene on bone mineral density, serum cholesterol concentrations and uterine endometrium in postmenopausal women N Engl J Med 337 1997 1641 1647
14. E.F. Eriksen Normal and pathological remodeling of human trabecular bone: Three dimensional reconstruction of the remodeling sequence in normals and in metabolic bone disease Endocr Rev 7 1986 379 408
15. B. Ettinger H.K. Genant C.E. Cann Postmenopausal bone loss is prevented by treatment with low-dosage estrogen with calcium Ann Intern Med 106 1987 40 45
16. J.C. Gallagher Estrogen: Prevention and treatment of osteoporosis Marcus R. Feldman D. Kelsey J. Osteoporosis 1996 Academic Press San Diego 1191 1208
17. P. Garnero P.D. Delmas New developments in biochemical markers for osteoporosis [review] Calcif Tissue Int 59 suppl 1 1996 S2 S9
18. P. Garnero E. Hausherr M.C. Chapuy Markers of bone resorption predict hip fracture in elderly women: The EPIDOS Prospective Study J Bone Miner Res 11 1996 1531 1538
19. H.K. Genant J. Lucas S. Weiss Low-dose esterified estrogen therapy Arch Intern Med 157 1997 2609 2615
20. G.S. Gordan J. Picchi B.S. Roof Antifracture efficacy of long-term estrogens for osteoporosis Trans Assoc Am Phys 86 1973 326 332
21. T.A. Hutchinson J.M. Polansky A.R. Feinstein Postmenopausal oestrogens protect against fracture of hip and distal radius Lancet 2 1979 705 709
22. R.E. Johnson E.E. Specht The risk of hip fracture in postmenopausal females with and without estrogen drug exposure Am J Public Health 71 1981 138 144
23. S. Khosla E.J. Atkinson Melton L.J. III Effects of age and estrogen status on serum parathyroid hormone levels and biochemical markers of bone turnover in women: A population based study J Clin Endocrinol Metab 82 1997 1522 1527
24. D.P. Kiel D.T. Felson J.J. Anderson Hip fracture and the use of estrogens in postmenopausal women N Engl J Med 317 1987 1169 1174
25. G.G.J.M. Kuiper E. Enmark M. Pelto-Huikko Cloning of a novel estrogen receptor expressed in rat prostate Proc Natl Acad Sci USA 93 1996 5925
26. F.N. Lafferty M.E. Fiske Postmenopausal oestrogen replacement: A long-term cohort study Am J Med 97 1994 66 77
27. R. Lindsay Estrogen deficiency Riggs B.L. Osteoporosis: Etiology, Diagnosis and Management 1995 Raven Press New York 133 160
28. R. Lindsay J. Tohme Estrogen treatment of patients with established postmenopausal osteoporosis Obstet Gynecol 76 1990 290 295
29. R. Lindsay D.M. Hart A. MacLean Bone response to termination of oestrogen treatment Lancet 7 1978 1325 1327
30. R. Lindsay J.W. Nieves C. Formica Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis Lancet 350 1997 550 555
31. E.G. Lufkin H.W. Wahner W.M. O'Fallon Treatment of postmenopausal osteoporosis with transdermal estrogen Ann Intern Med 117 1992 1 9
32. T.M. Mack M.C. Pike B.E. Henderson Estrogens and endometrial cancer in a retirement community N Engl J Med 294 1976 1262 1267
33. Marcus R. PEPI Trial Investigators Effects of hormone replacement therapies on bone mineral density results from the Postmenopausal Estrogen and Progestin Interventions Trial [abstract] J Bone Miner Res 10 suppl 1 1995 S30
34. Melton L.J. III Epidemiology of fractures Riggs B.L. Melton L.J. III Osteoporosis: Etiology, Diagnosis and Management 1995 Raven Press Philadelphia 225 248
35. L.E. Nachtigall R.H. Nachtigall R.D. Nachtigall Estrogen replacement therapy. I. A 10-year prospective study in the relationship to osteoporosis Obstet Gynecol 53 1979 277
36. T. Naessen I. Persson H.O. Adami Hormone replacement therapy and the risk for first hip fracture: A prospective, population-based cohort study Ann Intern Med 113 1990 95 103
37. J.W. Nieves L. Komar F. Cosman Calcium potentiates the effect of estrogen and calcitonin and bone mass: Review and analysis Am J Clin Nutr 67 1998 18 24
38. M.E. Ooms P. Lips J.C. Roos Vitamin D status and sex hormone binding globulin: Determinants of bone turnover and bone mineral density in elderly women J Bone Miner Res 10 1995 1177 1187
39. R. Pacifici Postmenopausal osteoporosis: How the hormonal changes of menopause cause bone loss Marcus R. Feldman D. Kelsey J. Osteoporosis 1996 Academic Press San Diego 727 743
40. A.M. Parfitt Skeletal heterogeneity and the purposes of bone remodeling: Implications for the understanding of osteoporosis Marcus R. Feldman D. Kelsey I. Osteoporosis 1996 Academic Press San Diego 315 329
41. B.L. Riggs S.F. Hodgson W.M. O'Fallon Effects of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis N Engl J Med 322 1990 802 809
42. B.L. Riggs E. Seeman S.F. Hodgson Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal women: Comparison with conventional therapy N Engl J Med 306 1982 446 450
43. R.K. Ross L. Bernstein Influence of sex hormones on breast cancer risk and mortality Lobo R. Treatment of the Postmenopausal Woman 1994 Raven Press New York 339 347
44. M.F. Sowers Premenopausal reproductive and hormonal characteristics and the risk for osteoporosis Marcus R. Feldman D. Kelsey J. Osteoporosis 1996 Academic Press San Diego 529 549
45. M.J. Stampfer F. Grodstein Role of hormone replacement in cardiovascular disease Lobo R. Treatment of the Postmenopausal Woman 1994 Raven Press New York 223 233
46. M.X. Tang D. Jacobs Y. Stern Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease Lancet 348 1996 429 432
47. S. Turken E. Siris D. Seldin Effects of tamoxifen on spinal bone density J Natl Cancer Inst 81 1989 1086 1088
48. S. Wallach P.H. Henneman Prolonged estrogen therapy in postmenopausal women JAMA 171 1959 1637 1642
49. J.S. Weiss C.L. Ure J.H. Ballard Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogens N Engl J Med 303 1980 1195 1198
50. A.R. Williams N.S. Weiss C. Ure Effect of weight, smoking, and estrogen use on the risk of hip and forearm fractures in post-menopausal women Obstet Gynecol 60 1982 695
51. S.J. Wimilawansa Combined therapy with estrogen and etidronate has an additive effect on bone mineral density in the hip and vertebrae: Four-year randomized study Am J Med 99 1995 36 42
52. J.K. Yeh M.M. Chen J.F. Aloia Effects of estrogen and growth hormone on skeleton in the ovariectomized rat with hypophysectomy Am J Physiol 273 1997 E734 E742
53. H.K. Ziel W.D. Finkle Increased risk of endometrial carcinoma among users of conjugated estrogens N Engl J Med 293 1975 1167 1170
54. Marcus R. Feldman D. Kelsey J. Osteoporosis 1996 Academic Press San Diego 716 1190